VEGF and IL-4 gene variability and its association with the risk of coronary heart disease in north Indian population

Molecular and Cellular Biochemistry

Volumn 341, Issue 1-2, 2010, Pages 139-148

  Sobti, R C ^a   Maithil, Nishi ^a   Thakur, Hitender ^a   Sharma, Yashpaul ^b   Talwar, K K ^b  

^a PANJAB UNIVERSITY   (India)

^b POSTGRADUATE INSTITUTE OF MEDICAL EDUCATION AND RESEARCH   (India)

Author keywords

Atherosclerosis; CHD; Cytokine; Genetic polymorphism; IL 4; VEGF

Indexed keywords

INTERLEUKIN 4; VASCULOTROPIN;

ADULT; ALLELE; ARTICLE; CORONARY RISK; DIABETES MELLITUS; GENE FREQUENCY; GENE INTERACTION; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; HUMAN; INDIAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MENTAL STRESS; OBESITY; PHENOTYPE;

AGED; ALCOHOL DRINKING; ALLELES; CASE-CONTROL STUDIES; CORONARY DISEASE; GENETIC ASSOCIATION STUDIES; GENOTYPE; HUMANS; INDIA; INTERLEUKIN-4; MIDDLE AGED; OBESITY; ODDS RATIO; POLYMORPHISM, GENETIC; RISK FACTORS; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 77955013389     PISSN: 03008177     EISSN: 15734919     Source Type: Journal    
DOI: 10.1007/s11010-010-0445-2     Document Type: Article

References (45)

1. P Libby PM Ridker A Maseri 2002 Inflammation and atherosclerosis Circulation 105 1135 1143 10.1161/hc0902.104353 1:CAS:528:DC%2BD38XislWhu7k%3D 11877368 (Pubitemid 34212626)
2. M Yokota S Ichihara TL Lin N Nakashima Y Yamada 2000 Association of a T29-C polymorphism of the transforming growth factor-beta1 gene with genetic susceptibility to myocardial infarction in Japanese Circulation 101 2783 2787 1:CAS:528:DC%2BD3cXksVCgtbk%3D 10859282
3. M Clauss M Gerlach H Gerlach J Brett F Wamg PC Familletti YC Pan JV Olander DT Connolly D Stern 1990 Vascular permeability factor: a tumor-derived polypeptide that induces endothelial cell and monocyte procoagulant activity, and promotes monocyte migration J Exp Med 172 1535 1545 10.1084/jem.172.6.1535 1:CAS:528:DyaK3cXmtV2lu70%3D 2258694
4. B Barleon S Sozzani D Zhou HA Weich A Mantovani D Marme 1996 Migration of human monocytes in response to vascular endothelial growth factor (VEGF) is mediated via the VEGF receptor flt-1 Blood 87 3336 3343 1:CAS:528: DyaK28Xit1Krs7k%3D 8605350
5. CL Grosskrutz B Anand-Apte C Duplaa TP Quinn BI Terman B Zetter PA D'Amore 1999 Vascular endothelial growth factor-induced migration of vascular smooth muscle cells in vitro Microvasc Res 58 128 136 10.1006/mvre.1999.2171 (Pubitemid 29419938)
6. FL Celletti JM Waugh PG Amabile A Brendolan PR Hilfiker MD Dake 2001 Vascular endothelial growth factor enhances atherosclerotic plaque progression Nature Med 7 425 429 10.1038/86490 1:CAS:528:DC%2BD3MXis1yls70%3D 11283668 (Pubitemid 32298544)
7. KB Lengstrom R Krebs AI Nykanen JM Tikkanen RK Sihvola EM Aaltola PJ Hayry PJ Wood K Alitalo S Yla-Herttuala PK Koskinen 2002 Vascular endothelial growth factor enhances cardiac allograft arteriosclerosis Circulation 105 2524 2530 10.1161/01.CIR.0000016821.76177.D2 (Pubitemid 34568975)
8. Q Zhao K Egashira S Inoue M Usui S Kitamoto W Ni M Ishibashi K Hiasa Ki T Ichiki M Shibuya A Takeshita 2002 Vascular endothelial growth factor is necessary in the development of arteriosclerosis by recruiting/activating monocytes in a rat model of long-term inhibition of nitric oxide synthesis Circulation 105 1110 1115 10.1161/hc0902.104718 1:CAS:528:DC%2BD38XislWhu7o%3D 11877364 (Pubitemid 34212623)
9. T Asahara C Bauters M Kearney C Pastore S Bunting S Rossow N Ferrara 1995 Local delivery of vascular endothelial growth factor accelerates re-endothelialization and attenuates intimal hyperplasia in balloon-injured rat carotid artery Circulation 91 2793 2801 1:CAS:528:DyaK2MXms1Sisr8%3D 7758186
10. E Van Belle L Maillard FO Tio JM Isner 1997 Accelerated endothelialization by local delivery of recombinant human vascular endothelial growth factor reduces in-stent intimal formation Biochem Biophys Res Comm 235 311 316 10.1006/bbrc.1997.6772 9199188 (Pubitemid 27313702)
11. Y Tsurumi K Krasinski D Chen B Witzenbichler M Kearney T Couffinhal JM Isner 1997 Reciprocal relationship between VEGF and NO in the regulation of endothelial integrity Nature Med 3 879 886 10.1038/nm0897-879 1:CAS:528:DyaK2sXltVKqurg%3D 9256279 (Pubitemid 27353448)
12. V Vincenti C Cassano M Rocchi G Persico 1996 Assignment of the vascular endothelial growth factor gene to human chromosome 6p21.3 Circulation 93 1493 1495 1:CAS:528:DyaK28XislGmurg%3D 8608615
13. CJ Watson NJA Webb MJ Bottomley PEC Brenchley 2000 Identification of polymorphisms within the vascular endothelial growth factor (VEGF) gene: correlation with variation in VEGF protein production Cytokine 12 1232 1235 10.1006/cyto.2000.0692 1:CAS:528:DC%2BD3cXltlOqsbw%3D 10930302 (Pubitemid 30611801)
14. M Shahbazi AA Fryer V Pravica IJ Brogan HM Ramsay IV Hutchinson 2002 Polymorphisms in vascular endothelial growth factor gene are associated with increased risk of acute rejection in renal transplant recipients J Am Soc Nephrol 13 260 264 1:CAS:528:DC%2BD38XltV2ntg%3D%3D 11752046
15. IJ Brogan N Khan K Isaac JA Hutchinson V Pravica IV Hutchinson 1999 Novel polymorphisms in the promoter and 59 untranslated regions of the human vascular endothelial growth factor gene Hum Immunol 60 1245 1249 10.1016/S0198-8859(99) 00132-9 1:CAS:528:DyaK1MXotVKru74%3D 10626738 (Pubitemid 30017507)
16. T Awata K Inoue S Kurihara T Ohkubo M Watanabe K Inukai I Inoue S Katayama 2002 A common polymorphism in the 59 untranslated region of the VEGF gene is associated with diabetic retinopathy in type 2 diabetes Diabetes 51 1635 1639 10.2337/diabetes.51.5.1635 1:CAS:528:DC%2BD38XjtlGmurk%3D 11978667
17. JK Liao 2004 Statins: potent vascular anti-inflammatory agents Int J Clin Pract 143 41 48 10.1111/j.1368-504X.2004.00375.x 1:CAS:528:DC%2BD2MXhtVemtr7F
18. P Aukrust A Yndestad T Waehre L Gullestad B Halvorsen JK Damas 2005 Inflammation in coronary artery disease: potential role for immunomodulatory therapy Expert Rev Cardiovasc Ther 3 1111 1124 10.1586/14779072.3.6.1111 1:CAS:528:DC%2BD2MXhtlGgsLjF 16293001 (Pubitemid 41748377)
19. AM Lefer XL Ma AS Weyrich R Scalia 1993 Mechanism of the cardioprotective effect of transforming growth factor beta 1 in feline myocardial ischemia and reperfusion Proc Natl Acad Sci USA 90 1018 1022 10.1073/pnas.90.3.1018 1:CAS:528:DyaK3sXpsFWjuw%3D%3D 8381531 (Pubitemid 23053942)
20. K Negoro Y Kinouchi N Hiwatashi S Takahashi S Takagi J Satoh T Shimosegawa T Toyota 1999 Crohn's disease is flanking region of the associated with novel polymorphisms in the tumor necrosis factor gene Gastroenterology 117 1062 1068 10.1016/S0016-5085(99)70390-2 1:CAS:528:DyaK1MXnsVCqsbs%3D 10535868 (Pubitemid 29512664)
21. RA Elkarim M Mustafa P Kivisakk H Link M Bakhiet 1998 Cytokine autoantibodies in multiple sclerosis, aseptic meningitis and stroke Eur J Clin Investig 28 295 299 10.1046/j.1365-2362.1998.00279.x 1:CAS:528: DyaK1cXjtFWjurc%3D (Pubitemid 28188305)
22. HM Kim HY Shin HJ Jeong NS Kim HJ Chae HR Kim HJ Song KY Kim SH Baek KS Cho BS Moon YM Lee 2000 Reduced IL-2 but elevated IL-4, IL-6, and IgE serum levels in patients with cerebral infarction during the acute stage J Mol Neurosci 14 191 196 10.1385/JMN:14:3:191 10984195
23. U Nanavaty AD Goldstein SJ Levine 2001 Polymorphisms in candidate asthma genes Am J Med Sci 321 11 16 10.1097/00000441-200101000-00003 1:STN:280:DC%2BD3M7hvVyqsg%3D%3D 11202474
24. FJ Bijlsma K Van H Van E Jonge N Tilanus FH Gmelig-Meyling RA de Weger 2002 Acute cardiac transplant rejection is associated with low frequencies of interleukin-4 producing helper T-lymphocytes rather than with interleukin-4 promoter or splice variants Hum Immunol 63 317 323 10.1016/S0198-8859(02)00370-1 1:CAS:528:DC%2BD38XitlGhurw%3D 12039414 (Pubitemid 34303703)
25. WP Maksymowych ME Suarez-Almazor H Buenviaje BL Cooper C Degeus M Thompson AS Russell 2002 HLA and cytokine gene polymorphisms in relation to occurrence of palindromic rheumatism and its progression to rheumatoid arthritis J Rheumatol 29 2319 2326 1:CAS:528:DC%2BD38XptVGgtr0%3D 12415587
26. EE Nakayama L Meyer A Iwamoto A Persoz Y Nagai C Rouzioux JF Delfraissy P Debre D McIlroy I Theodorou T Shioda 2003 SEROCO Study Group Protective effect of interleukin-4589T polymorphism on human immunodeficiency virus type 1 disease progression: relationship with virus load J Infect Dis 185 1183 1186 10.1086/339825
27. TL Bugawan DB Mirel AM Valdes A Panelo P Pozzilli HA Erlich 2003 Association and interaction of the IL4R, IL4, and IL13 loci with type 1 diabetes among Filipinos Am J Hum Genet 72 1505 1514 10.1086/375655 1:CAS:528: DC%2BD3sXktlyitL4%3D 12748907 (Pubitemid 36628389)
28. RYL Zee NR Cook S Cheng R Reynolds HA Erlich K Lindpaintner PM Ridker 2004 Polymorphism in the P-selectin and interleukin-4 genes as determinants of stroke: a population-based, prospective genetic analysis Hum Mol Genet 13 389 396 10.1093/hmg/ddh039 1:CAS:528:DC%2BD2cXos1aluw%3D%3D 14681304 (Pubitemid 38239790)
29. SF Debora L Flynt K Bourgeois RA Panettieri A Stephanie 2006 Interleukin-13 and interleukin-4 induce vascular endothelial growth factor release from airway smooth muscle cells role of vascular endothelial growth factor genotype Am J Respir Cell Mol Biol 34 213 218 10.1165/rcmb.2005-0147OC (Pubitemid 43202468)
30. FJ Tsai CH Chang CC Chen TC Hsia HY Chen WC Chen 2005 Interleukin-4 gene intron-3 polymorphism is associated with transitional cell carcinoma of the urinary bladder BJU Int 95 430 435 10.1111/j.1464-410X.2005.05315.x (Pubitemid 40283139)
31. JK Field T Liloglou S Xinarianos GP Prime W Fielding JM Walshaw L Turnbull 1999 Genetic alterations in bronchial lavage as a potential marker for individuals with a high risk of developing lung cancer Cancer Res 59 2690 2695 1:CAS:528:DyaK1MXjs1ymtrY%3D 10363993
32. WM Howell S Ali MJ Rose-Zerilli S Ye 2005 VEGF polymorphisms and severity of atherosclerosis J Med Genet 42 485 490 10.1136/jmg.2004.025734 1:CAS:528:DC%2BD2MXmt1Citb0%3D 15937083 (Pubitemid 40847236)
33. R Mout R Willemze JE Landegent 1991 Repeat polymorphisms in the interleukin-4 gene Nucl Acids Res 19 3763 10.1093/nar/19.13.3763 1:CAS:528:DyaK3MXlt1yqt78%3D 1804125
34. A Stevens J Soden PE Brenchley S Ralph DW Ray 2003 Haplotype analysis of the polymorphic human vascular endothelial growth factor gene promoter Cancer Res 63 812 816 1:CAS:528:DC%2BD3sXht1Gqs7k%3D 12591731
35. KS Moulton K Vakili D Zurakowski M Soliman C Butterfield E Sylvin KM Lo S Gillies K Javaherian J Folkman 2003 Inhibition of plaque neovascularization reduces marcrophage accumulation and progression of advanced atherosclerosis Proc Natl Acad Sci USA 100 4736 4741 10.1073/pnas.0730843100 1:CAS:528:DC%2BD3sXjt12nsLo%3D 12682294 (Pubitemid 36457799)
36. D Ray M Mishra S Ralph I Read R Davies P Brenchley 2004 Association of the VEGF gene with proliferative diabetic retinopathy but not proteinuria in diabetes Diabetes 53 861 864 10.2337/diabetes.53.3.861 1:CAS:528: DC%2BD2cXhvFeksL8%3D 14988276 (Pubitemid 38270661)
37. P Krippl U Langsenlehner W Renner B Yazdani-Biuki G Wolf TC Wascher B Paulweber J Haas H Samonigg 2003 A common 936 C/T gene polymorphism of vascular endothelial growth factor is associated with decreased breast cancer risk Int J Cancer 106 468 471 10.1002/ijc.11238 1:CAS:528:DC%2BD3sXmtlyqu7Y%3D 12845639 (Pubitemid 36966201)
38. KC Smith AC Bateman HM Fussell WM Howell 2004 Cytokine gene polymorphisms and breast cancer susceptibility and prognosis Eur J Immunogenet 4 167 173 10.1111/j.1365-2370.2004.00462.x (Pubitemid 39049861)
39. EJ Jacobs HS Feigelson EB Bain KA Brady C Rodriguez VL Stevens AV Patel 2006 Polymorphisms in the vascular endothelial growth factor gene and breast cancer in the Cancer Prevention Study II cohort Breast Cancer Res 8 R22 10.1186/bcr1400 16613616 (Pubitemid 44377909)
40. SL Mccarron S Edwards PR Evans R Gibbs DP Dearnaley A Dowe C Southgate DF Easton RA Feles WM Howell 2002 Influence of cytokine gene polymorphisms on the development of prostate cancer Cancer Res 12 3369 3372
41. R Del Bo M Scarlato S Ghezzi A Maestreni L Sjolind C Forsblom M Wessman PH Groop GP Comi M Bresolin L Luzi G Zerbini 2006 VEGF gene variability and type 1 diabetes: evidence for a protective role Immunogenetics 58 107 112 10.1007/s00251-006-0089-2 16508738
42. B Yang DF Cross M Ollerenshaw BA Millward AG Demaine 2003 Polymorphisms of the vascular endothelial growth factor and susceptibility to diabetic microvascular complications in patients with type 1 diabetes mellitus J Diabetes Complic 17 1 6 10.1016/S1056-8727(02)00181-2 (Pubitemid 36042784)
43. M Buracznska P Ksiazek I Baranowicz-Gaszczyk L Jozwiak 2007 Association of the VEGF gene polymorphism with diabetic retinopathy in type 2 diabetic patients Nephrol Dial Transpl 22 827 832 10.1093/ndt/gfl641 (Pubitemid 46351692)
44. A Tedgui Z Mallat 2006 Cytokines in atherosclerosis: pathogenic and regulatory pathways Physiol Rev 86 515 581 10.1152/physrev.00024.2005 1:CAS:528:DC%2BD28Xktlylu7g%3D 16601268
45. YH Chang CN Huang CY Wu MY Shiau 2005 Association of interleukin-10 A-592C and T-819C polymorphisms with type 2 diabetes mellitus Hum Immunol 66 1258 1263 10.1016/j.humimm.2005.05.001 1:CAS:528:DC%2BD28XksVajtLw%3D 16690414